Exhibition
QTP104, mRNA vaccine for COVID-19
QTP104 is a COVID-19 mRNA vaccine. It consists of self-replicating mRNA and Lipid inorganic nanoparticles (LIONs).
Negotiable Min Order Quantity Unit
- Required Quantity
-
- Place of Origin
- South Korea
- Payment Terms
- Others
- Production method
- OBM
- Shipping / Lead Time
- Negotiable / Negotiable
- Keyword
- vaccine, quratis, covid-19 vaccine, lnp
- Category
- Other Pharmaceuticals
Apply a video call to the Supplier
South Korea
| Product name | QTP104, mRNA vaccine for COVID-19 | Certification | - |
|---|---|---|---|
| Category | Other Pharmaceuticals | Material | - |
| Keyword | vaccine , quratis , covid-19 vaccine , lnp | Unit Size | - |
| Brand name | - | Unit Weigh | - |
| origin | South Korea | Stock | 0 |
| Supply type | OBM | HS code | - |
Product Information
RNA vaccine technology is attracting attention to prevent COVID-19. When injected vaccine, it created antigens directly in the cell and stimulates immunity. RNA vaccine can be mass-produced in a short period of time and act as immune adjuvants.
Especially, the characteristic of our RNA vaccine technology is self-amplifying. Even if small doses are inoculated, it is effective enough, and there is no PEG component that causes allergies, so side effects can be minimized.
The most important technique in RNA vaccine is to deliver RNA into cells. Our RNA vaccine is protected by our LNP technology called LIONs(Lipid inorganic nanoparticles). It protects RNA and delivers RNA to cells without decomposing.
QTP104 is undergoing to Phase 1 clinical trial in South Korea.
B2B Trade
| Price (FOB) | Negotiable | transportation | Negotiation Other |
|---|---|---|---|
| MOQ | Negotiable | Leadtime | Negotiable |
| Payment Options | Others | Shipping time | Negotiable |
- President
- Kwan Goo Cho
- Address
- 327 Gangnam-daero ,9th fl. Daeryeong Seocho Tower, Seocho-gu, Seoul, Korea
- Product Category
- Other Pharmaceuticals
- Year Established
- 2016
- No. of Total Employees
- 101-500
- Company introduction
-
Our body's immune system will be activated,
and our body will be able to cope with the
pathogens that will invade in the future.
- Main Markets
-
Indonesia
Malaysia
Philippines
Thailand
Viet Nam
- Main Product
